First-time Diabetic Ketoacidosis in Type 2 Diabetics With Covid-19 Infection: A
Novel Case Series
#MMPMID32912646
Croft A
; Bucca A
; Jansen JH
; Motzkus C
; Herbert A
; Wang A
; Hunter BR
J Emerg Med
2020[Nov]; 59
(5
): e193-e197
PMID32912646
show ga
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 is a novel
coronavirus first diagnosed in U.S. hospitals in January 2020. Typical presenting
symptoms include fever, dry cough, dyspnea, and hypoxia. However, several other
symptoms have been reported, including fatigue, weakness, diarrhea, and abdominal
pain. We have identified a series of patients with diabetic ketoacidosis (DKA)
likely precipitated by coronavirus disease 2019 (COVID-19). CASE SERIES: We
describe 5 patients with previously known type 2 diabetes and no history of DKA,
who presented to the emergency department with new-onset DKA and COVID-19. WHY
SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Diabetes mellitus is a known
risk factor for poor outcomes in viral respiratory illnesses, including COVID-19.
Infection may precipitate DKA in patients with type 2 diabetes. Aggressive
management of these patients is recommended; however, management guidelines have
not yet been put forth for this unique subset of patients.
|Anti-Bacterial Agents/therapeutic use
[MESH]
|COVID-19/*complications/diagnosis/therapy
[MESH]
|Crystalloid Solutions/therapeutic use
[MESH]
|Diabetes Mellitus, Type 2/*complications/drug therapy
[MESH]
free
free
free
